ZEO vs ONCO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

ZEO

28.7
AI Score
VS
ONCO Wins

ONCO

36.3
AI Score

Investment Advisor Scores

ZEO

29score
Recommendation
AVOID NEW MONEY

ONCO

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ZEO ONCO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -10.7% -83.9% ZEO
Earnings Growth -95.8% 0.0% ONCO
Tradestie Score 28.7/100 36.3/100 ONCO
Profit Margin -15.4% 0.0% ONCO
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

ZEO 1M: +30.4% · 3M: -53.5% ONCO 1M: +8.8% · 3M: -33.3%

Current Technical Phase

ZEO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -23.3%), weak momentum, RSI 44

RSI (14): 43.5 · Price: $0.29

ONCO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $0.73

Fundamentals Snapshot

Metric ZEO ONCO
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — 0.0
Revenue (TTM) — —
Revenue Growth -0.1% -0.8%
Gross Margin 0.5% 0.8%
Operating Margin -0.2% -131.1%
EPS -0.27 749.08
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ONCO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.